AbbVie Beats Q3 Estimates with EPS of $3.82 and Revenue of $17.4B, Up 10% YoY
According to AbbVie's Q3 2026 earnings report, the pharmaceutical company reported adjusted earnings per share of $3.82, exceeding market expectations of $3.74. Net revenues reached $17.4 billion, surpassing the forecasted $17.34 billion and marking 10% year-over-year
ABBV+1.87%
GateNews·10-30 11:49
